Surescripts, the nation’s leading health information network, will lead two sessions at the National Council for Prescription Drug Programs (NCPDP) Annual Technology & Business Conference on May 9, 2023, on Opportunities to Expand Access & Fill Gaps in Primary Care and Improving Sig Clarity: Tools…
Nuvo Group Ltd. (“Nuvo” or “the Company”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp I (NASDAQ: LGVC) (“LAMF”), a special purpose acquisition company (“SPAC”), today announced that they have entered…
Dexcom, Inc. (NASDAQ : DXCM), un chef de file à l’échelle internationale dans le domaine de la surveillance du glucose en continu (SGC) et en temps réel pour les personnes atteintes de diabète, se réjouit de l’élargissement progressif de la…
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. The growth in the global AI-enabled medical…
today reported its financial results as of and for the quarter ended March 31, 2023. “Given the strength of our first quarter results and an expanding market opportunity with new CGM coverage now available, we are pleased to raise our…
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023. “I am proud of our team for driving excellent first quarter results and staying focused on serving our customers”Tweet this First Quarter 2023 Highlights “I…
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for…
Stallergenes Greer, ein biopharmazeutisches Unternehmen, das sich auf die Erforschung, Diagnose und Behandlung von Allergien der Atemwege spezialisiert hat, freut sich, seine strategische Ausrichtung für die Stallergenes Greer Foundation bekannt zu geben. Die unter der Schirmherrschaft der Fondation de France…
Acuamark Diagnostics has appointed Giulia Kennedy, Ph.D., formerly global chief scientific officer and chief medical officer of diagnostics company Veracyte, to its board of directors. “With sharp intellect, deep humanity and decades of in-depth genomic diagnostic development, company building, and commercialization experience, she…
Mahana Therapeutics, a leading developer of digital therapeutics designed to empower people with chronic conditions to lead fuller lives, today announced that it has completed Service Organization Control (SOC) 2 Type II audit for its world class digital therapeutic offering.…
GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures. The flagship intraoperative ultrasound imaging system, developed by BK Medical – a subsidiary of GE HealthCare, was designed to…
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year…